It’s a testimony to the underlying science, the effectiveness of their R&D and management that CXL have been able to convince others to fund their development. Cash flow positive and profitable with all the upside from some very attractive verticals with huge addressable markets. There’s a lot like about CXL.
Ann: Calix receives R&D rebate, welcomes recent policy changes, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $163.4M | |||
| Open | High | Low | Value | Volume |
| 90.0¢ | 91.0¢ | 88.0¢ | $318.3K | 354.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 8001 | 90.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.0¢ | 2770 | 14 |
View Market Depth
| Last trade - 15.47pm 04/09/2024 (20 minute delay) ? |
| CXL (ASX) Chart |